What Motion Informatics does

Motion Informatics Ltd. is an Israel-based medical technology company founded in 2014 that builds AI-driven adaptive neuromuscular stimulation platforms for stroke and neurological rehabilitation. Its product portfolio centers on three systems sharing the proprietary BioRhythmIQ signal processing architecture: STIMEL-03, an FDA-cleared EMG-triggered closed-loop stimulation device with up to 8 stimulation channels and adaptive threshold control; Spatial StimelMD (SSMD), a next-generation platform integrating AR biofeedback, FES/NMES, and cloud-based remote patient monitoring with Therapist (SSMD-T), Home (SSMD-H), and Remote (SSMD-R) deployment variants; and Axionis-Kynara, an in-development predictive neurorehabilitation platform incorporating Brain-Computer Interface technology.

The core technology fuses real-time electrophysiology, adaptive stimulation, and spatial computing to detect voluntary motor intent and deliver precisely timed, intent-triggered stimulation. Proprietary algorithms decode neuromuscular intent at a 2,000 Hz sampling rate with sub-8ms trigger latency and sensitivity down to 10-30 microvolts, enabling detection of sub-visible descending neural drive. The platform operates on three AI levels — real-time signal interpretation, longitudinal trend analysis, and structured clinical reporting — and is anchored by US Patent No. 7,221,980 B2. STIMEL-03 holds FDA Breakthrough Device Designation, while Spatial StimelMD is under FDA 510(k) and CE-MDR review.

The company monetizes primarily through hardware sales of clinical-grade devices, supplemented by recurring cloud and remote-monitoring subscriptions on AWS infrastructure. Its go-to-market combines direct enterprise sales for hospitals and rehabilitation centers with a channel-first model: 40+ certified regional distributors with exclusive territory rights span four continents, and an exclusive U.S. distribution partnership with ReShape Lifesciences was signed in September 2025. Customer segments include hospitals and rehabilitation clinics (primary), home healthcare users, physicians and physical therapists, and regional medical technology distributors. Pricing is quote-based, undisclosed publicly, and structured around multi-year enterprise contracts.

Name

Motion Informatics

Legal name

Motion Informatics Ltd.

Website

https://motioninformatics.ai

Company type

Private

Founded year

2014

Operating status

Operating

Headcount range

11–50 employees

Short description

Motion Informatics Ltd. is an Israel-based medical technology company that develops AI-driven, EMG-triggered neuromuscular stimulation platforms (STIMEL-03, Spatial StimelMD, Axionis-Kynara) for hospitals, rehabilitation clinics, and home users treating stroke and neurological injury.

Ownership category

akta.pro rank

Product category

Neuromuscular Rehabilitation Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Home Health Care Services (62161), Offices of Physical, Occupational and Speech Therapists, and Audiologists (62134)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Rehabilitation Therapy Equipment (PT/OT Modalities, Exercise & Balance Devices) (HLAHAMAG)

akta.pro secondary industries

Digital Rehabilitation & Physical Therapy Therapeutics (HLACANAJ), Neurologic Rehabilitation (Stroke, TBI, Parkinson’s, MS) (HSADAIAC), Assistive Technology, Adaptive Equipment & Home Exercise Program Training In-Home (HSABADAN)

Keywords

• Neuromuscular rehabilitation devices
• Functional electrical stimulation
• EMG biofeedback therapy
• Stroke rehabilitation technology
• Adaptive neurostimulation systems

Headquarters

HQ city

Haifa

HQ country

Israel

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure, Supply Chain

Revenue model

1. Medical Device Sales: Sale of FDA-cleared and CE-MDR submitted neuromuscular stimulation devices including STIMEL-03 and Spatial StimelMD. Devices are sold to clinical centers, hospitals, and directly to patients for home use, representing the primary revenue stream.
2. Cloud Services & Data Platform: Associated cloud services for rehabilitation session data storage, therapist monitoring, and remote patient monitoring via the SSMD platform. AWS-based secure data storage and processing infrastructure supports ongoing service revenue.
3. Distributor Partnership Revenue: Revenue generated through distributor network partnerships including exclusive territory arrangements, with competitive distributor pricing, volume incentives, and performance-based rebate structures.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels6 records

Core offering

Motion Informatics designs, develops, and sells AI-driven adaptive neuromuscular stimulation medical devices for post-stroke and neurological rehabilitation. Its products combine real-time EMG biofeedback, Functional Electrical Stimulation (FES), Neuromuscular Electrical Stimulation (NMES), augmented reality biofeedback, and proprietary BioRhythmIQ adaptive signal processing to decode patient motor intent and deliver intent-triggered therapy across clinical and home settings.

Product overview

Motion Informatics builds a unified computational treatment platform that fuses real-time electrophysiology, adaptive stimulation, and spatial computing for neuromuscular rehabilitation. The portfolio centers on three products: the FDA-cleared STIMEL-03 as the flagship EMG-triggered stimulation device; the next-generation Spatial StimelMD (SSMD) platform adding AI-powered analytics and AR immersive biofeedback with therapist, home, and remote deployment variants; and the Axionis-Kynara (in development) as a predictive neurorehabilitation module incorporating Brain-Computer Interface technology. All products share the proprietary BioRhythmIQ adaptive threshold technology and closed-loop control architecture.

Differentiator

Problem solved

Functional benefit

Brands

• STIMEL-03: FDA-cleared intelligent closed-loop neuromuscular stimulation system for post-stroke and neurological rehabilitation with EMG-triggered stimulation, adaptive threshold control, and multi-channel precision.
• Spatial StimelMD
• Axionis-Kynara
• BioRhythmIQ

Products and services

• STIMEL-03 FDA-cleared, EMG-driven intelligent closed-loop neuromuscular stimulation system integrating Functional Electrical Stimulation (FES), Neuromuscular Electrical Stimulation (NMES), and real-time biofeedback. Powered by BioRhythmIQ technology, it captures electromyographic signals, analyzes neuromotor intent in real time, and delivers intent-triggered stimulation to reinforce correct motor activation patterns in post-stroke and neurological rehabilitation for hospitals, rehabilitation centers, and physical therapy clinics.
• Spatial StimelMD (SSMD) Next-generation neuromuscular rehabilitation platform integrating AI, Augmented Reality (AR), FES, NMES, real-time biofeedback, and BioRhythmIQ technology into a unified adaptive clinical ecosystem. Includes SSMD-T (Therapist Unit), SSMD-H (Home Unit), and SSMD-R (Remote Module) variants supporting immersive AR therapy, AI-driven adaptation, multi-modal stimulation, and remote patient monitoring for clinicians and home users.
• Axionis-Kynara AI-powered predictive neurorehabilitation platform combining AI, AR, FES, NMES, real-time biofeedback, Brain-Computer Interface (BCI), and BioRhythmIQ technology. Designed to decode patient intent in real time and deliver predictive stimulation before movement is fully expressed for personalized motor recovery from stroke, spinal cord injury, and traumatic brain injury.

Quantifiable outcome

• Recovery is 2.3x faster than controls with fewer sessions
• +6 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature7 records

Partnerships

One partnership is on record.

• ReShape LifesciencescoreChannel Partner/ Reseller/ Distributor · 4 September 2025ReShape Lifesciences entered an exclusive U.S. distribution agreement with Motion Informatics to market the FDA-cleared Stimel-03 neuromuscular rehabilitation device and Spatial StimelMD system. The partnership expands ReShape's portfolio beyond weight-loss and metabolic health solutions into neurorehabilitation, leveraging their established commercial reach to distribute AI and AR-enabled rehabilitation technology across the U.S. market.

Scale indicators7 records

Recent moves8 records

Expansion highlights7 records

Broad incumbents

• Ottobock: Ottobock is a global incumbent in prosthetics, orthotics, and rehabilitation technology, with FES and neurostimulation offerings that overlap with Motion Informatics' clinical rehabilitation focus.
• NeuroPace: NeuroPace is an implantable neuromodulation company (RNS System) for epilepsy, broadly comparable as a neurotechnology platform with FDA-cleared neurostimulation hardware.

Emerging players

• Myomo: Myomo offers myoelectric orthoses that use EMG signals to assist arm movement, closely related to Motion Informatics' EMG-triggered neuromuscular stimulation concept for stroke patients.
• ReWalk Robotics: ReWalk develops wearable robotic exoskeletons for spinal cord injury and stroke rehabilitation, an adjacent technology competing for the same hospital/clinic rehab budgets.
• Ekso Bionics: Ekso Bionics develops wearable exoskeletons for stroke and spinal cord injury rehabilitation, competing with Motion Informatics in the clinic-based neuro-rehab capital equipment segment.

Direct peers

• Bioness (Bioventus): Bioness (acquired by Bioventus) is a direct competitor in functional electrical stimulation (FES) devices for stroke and orthopedic rehabilitation, with overlapping L300 Go and H200 Wireless products serving the same clinical use cases as STIMEL-03.
• Saebo: Saebo specializes in upper-limb stroke rehabilitation devices and orthoses, directly competing with Motion Informatics in the post-stroke motor recovery clinic and home segments targeted by SSMD-T and SSMD-H.
• Hocoma (DIH Medical): DIH/Hocoma provides robotic and sensor-based rehabilitation technologies (Lokomat, Armeo) for clinics and hospitals, competing for the same neurorehabilitation budgets as Motion Informatics' Spatial StimelMD.
• Tyromotion: Tyromotion builds computer-assisted rehabilitation devices for upper and lower extremities, closely comparable to Motion Informatics' AR-integrated, multi-modal SSMD platform in stroke and neuro rehab clinics.
• Restorative Therapies: Restorative Therapies provides FES-based cycling and rehab systems (RT300, Xcite) for neurological recovery, directly comparable to Motion Informatics' intent-triggered NMES/FES approach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/profile.php
• LinkedInlinkedin.com/company/motion-informatics

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Motion Informatics